Premier Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-32,700
| Closed | -$1.24M | – | 115 |
|
|
2018
Q4 | $1.24M | Buy |
32,700
+2,425
| +8% | +$92.1K | 0.33% | 51 |
|
|
2018
Q3 | $1.2M | Sell |
30,275
-1,100
| -4% | -$43.5K | 0.27% | 54 |
|
|
2018
Q2 | $1.1M | Sell |
31,375
-1,500
| -5% | -$52.7K | 0.26% | 57 |
|
|
2018
Q1 | $1.15M | Buy |
32,875
+1,650
| +5% | +$57.7K | 0.26% | 58 |
|
|
2017
Q4 | $1.08M | Sell |
31,225
-150
| -0.5% | -$5.21K | 0.24% | 63 |
|
|
2017
Q3 | $1.06M | Buy |
31,375
+275
| +0.9% | +$9.32K | 0.24% | 57 |
|
|
2017
Q2 | $1.06M | Sell |
31,100
-1,000
| -3% | -$34.1K | 0.24% | 55 |
|
|
2017
Q1 | $1M | Buy |
32,100
+1,940
| +6% | +$60.4K | 0.24% | 58 |
|
|
2016
Q4 | $823K | Sell |
30,160
-15,600
| -34% | -$426K | 0.21% | 61 |
|
|
2016
Q3 | $1.5M | Buy |
45,760
+20,875
| +84% | +$686K | 0.37% | 38 |
|
|
2016
Q2 | $751K | Buy |
24,885
+9,235
| +59% | +$279K | 0.19% | 58 |
|
|
2016
Q1 | $440K | Hold |
15,650
| – | – | 0.11% | 66 |
|
|
2015
Q4 | $531K | Sell |
15,650
-100
| -0.6% | -$3.39K | 0.13% | 53 |
|
|
2015
Q3 | $501K | Hold |
15,750
| – | – | 0.13% | 55 |
|
|
2015
Q2 | $501K | Buy |
15,750
+1,550
| +11% | +$49.3K | 0.12% | 58 |
|
|
2015
Q1 | $485K | Buy |
14,200
+3,000
| +27% | +$102K | 0.11% | 60 |
|
|
2014
Q4 | $394K | Buy |
11,200
+550
| +5% | +$19.3K | 0.1% | 66 |
|
|
2014
Q3 | $380K | Sell |
10,650
-1,700
| -14% | -$60.7K | 0.1% | 68 |
|
|
2014
Q2 | $458K | Hold |
12,350
| – | – | 0.12% | 64 |
|
|
2014
Q1 | $400K | Sell |
12,350
-250
| -2% | -$8.1K | 0.11% | 65 |
|
|
2013
Q4 | $374K | Hold |
12,600
| – | – | 0.1% | 67 |
|
|
2013
Q3 | $327K | Buy |
+12,600
| New | +$327K | 0.09% | 72 |
|